2026 NPPES data Obesity Medicine (Internal Medicine) Physician NPI 1952509192 MB, BCH
Verify on CMS →

SAMAR HAFIDA, MB, BCH

Obesity Medicine (Internal Medicine) Physician in BOSTON, Massachusetts. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
986
Medicare Part D claims · 148 beneficiaries · Obesity Medicine (Internal Medicine) Physician avg: 1K
Generic prescribing
26%
generic claims · 74% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$49.95
1 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

SAMAR HAFIDA, MB, BCH filed 986 Medicare Part D claims in 2023 as a Obesity Medicine (Internal Medicine) Physician in BOSTON, Massachusetts, prescribing 26% generic.

986
Part D claims, 2023
26%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

SAMAR HAFIDA, MB, BCH's Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

986 Top 25% higher than 75% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). Below this entry. 400–600: 90,619 prescribers (7%). Below this entry. 600–800: 56,224 prescribers (4%). Below this entry. 800–1,000: 40,919 prescribers (3%). This entry sits in this band. 1,000–1,200: 31,827 prescribers (2%). Above this entry. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2,000–2,200: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board certification likely (heuristic — not verified)

SAMAR HAFIDA, MB, BCH practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about SAMAR HAFIDA, MB, BCH?

Quality data not reported

NPI registry status

Active

Issued 07/10/2007

NPI 1952509192

Primary specialty

Obesity Medicine (Internal Medicine) Physician

Rare

142 US NPIs in this specialty

Medicare Part D claims

986 6% vs specialty avg

2023 prescription claims

Specialty avg: 1,046

Specialty distribution in Massachusetts

How Obesity Medicine (Internal Medicine) Physician compares to other specialties among Massachusetts providers

Massachusetts providers

Obesity Medicine (Internal Medicine) Physician share within Massachusetts

1. Obesity Medicine (Internal Medicine) Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Obesity Medicine (Internal Medicine) Physician share within Massachusetts

Specialty board-certification context

Estimated specialty board-certified rate — Obesity Medicine (Internal Medicine) Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Obesity Medicine (Internal Medicine) Physician ABMS/AOA estimate

Est. board-certified rate (Obesity Medicine (Internal Medicine) Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Obesity Medicine (Internal Medicine) Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

SAMAR HAFIDA, MB, BCH appears in the CMS NPPES registry as a Obesity Medicine (Internal Medicine) Physician provider holding MB, BCH credentials at 732 HARRISON AVE, FL 2, BOSTON, MA, 02118, with a listed phone of (617) 638-7470. NPI 1952509192 was issued on 07/10/2007. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what HAFIDA most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 986 prescription claims written by this provider, covering 148 Medicare beneficiaries and totaling roughly $815K in drug spend, split 74% brand-name and 26% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Obesity Medicine (Internal Medicine) Physician is a narrow specialty nationwide, with 142 enrolled providers across 36 states and an average of 1,046 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

732 HARRISON AVE, FL 2
BOSTON, MA 02118

Provider Details

NPI 1952509192
Specialty Obesity Medicine (Internal Medicine) Physician
Credentials MB, BCH
Gender Female
NPI Issued 07/10/2007

Hospital and facility affiliations

Facilities where SAMAR HAFIDA, MB, BCH bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

EVANS MEDICAL FOUNDATION INC
BOSTON, MA

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for SAMAR HAFIDA, MB, BCH. Source: openpaymentsdata.cms.gov.

Total received

$50

Largest payer

Abbott Laboratories

Most common payment type

Long term medical supply or device loan

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — Massachusetts BORIM 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~38K Massachusetts medical licensees in 2023 — they are NOT specific to SAMAR HAFIDA, MB, BCH. To verify SAMAR HAFIDA, MB, BCH's current license status, search the BORIM public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

80
Total board actions, Massachusetts 2023
Across 78 cases
2.11
Actions per 1,000 licensees
Massachusetts statewide rate
probation
Most common action type
29 cases

BORIM publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Massachusetts disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Brand-heavy

SAMAR HAFIDA, MB, BCH — brand share 74.0%
Specialty average (est.)

74% brand-name claims vs 26% generic, on 986 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

986
Total Claims
$815K
Total Drug Cost
148
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
1,604
Total Day Supply
46,646
Brand vs Generic
74% brand / 26% generic
Brand Drug Cost
$799K
Generic Drug Cost
$5K

Patient Demographics

Average Patient Age
63.9 years
Avg HCC Risk Score
1.77
Gender Split
65% female / 35% male
Age Distribution
<65: 63, 65-74: 54, 75-84: N/A, 85+: N/A

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What SAMAR HAFIDA, MB, BCH prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Trulicity
Dulaglutide
207
Ozempic
Semaglutide
126
Mounjaro
Tirzepatide
81
Jardiance
Empagliflozin
49
Synjardy Xr
Empagliflozin/Metformin Hcl
30
Atorvastatin Calcium
28
Tresiba Flextouch U-100
Insulin Degludec
22
Invokana
Canagliflozin
17
Metformin Hcl
16
Metformin Hcl Er
Metformin Hcl
16

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Obesity Medicine (Internal Medicine) Physician Overview

How SAMAR HAFIDA, MB, BCH fits within the Obesity Medicine (Internal Medicine) Physician landscape nationally.

142
Obesity Medicine (Internal Medicine) Physician Providers in US
36
States with Obesity Medicine (Internal Medicine) Physician
1,046
Avg Claims per Provider

SAMAR HAFIDA, MB, BCH's 986 claims are below the specialty average of 1,046.

Nearby Obesity Medicine (Internal Medicine) Physician Providers in Massachusetts

Other clinicians with the same primary specialty enrolled in Massachusetts, drawn from the same CMS NPPES roster as HAFIDA.

Compare Obesity Medicine (Internal Medicine) Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is SAMAR HAFIDA, MB, BCH's specialty?
SAMAR HAFIDA, MB, BCH specializes in Obesity Medicine (Internal Medicine) Physician and practices in BOSTON, Massachusetts. Credentials: MB, BCH.
How much does SAMAR HAFIDA, MB, BCH prescribe under Medicare Part D?
In 2023, SAMAR HAFIDA, MB, BCH wrote 986 Medicare Part D claims totaling $815K in drug costs for 148 beneficiaries.
Where is SAMAR HAFIDA, MB, BCH located?
SAMAR HAFIDA, MB, BCH is located at 732 HARRISON AVE, FL 2, BOSTON, MA, 02118. Phone: (617) 638-7470.
What is SAMAR HAFIDA, MB, BCH's NPI number?
SAMAR HAFIDA, MB, BCH's National Provider Identifier (NPI) is 1952509192, issued on 07/10/2007.
Does SAMAR HAFIDA, MB, BCH prescribe more brand-name or generic drugs?
SAMAR HAFIDA, MB, BCH's prescribing is 74% brand-name and 26% generic drugs by claim count, with $799K in brand drug costs.
How many Obesity Medicine (Internal Medicine) Physician providers are there in the US?
There are 142 Obesity Medicine (Internal Medicine) Physician providers across 36 states in the US. The average Obesity Medicine (Internal Medicine) Physician provider writes 1,046 Medicare Part D claims per year.
What drugs does SAMAR HAFIDA, MB, BCH prescribe most often?
Based on 2023 Medicare Part D data, SAMAR HAFIDA, MB, BCH's most frequently prescribed drugs include Trulicity, Ozempic, Mounjaro. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does SAMAR HAFIDA, MB, BCH accept Medicare?
SAMAR HAFIDA, MB, BCH appears in CMS Medicare data with 986 Part D claims and 148 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify SAMAR HAFIDA, MB, BCH's credentials?
SAMAR HAFIDA, MB, BCH's NPI is 1952509192 with credentials MB, BCH. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology